Literature DB >> 6201076

Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.

J Holden, A Churg.   

Abstract

Using formalin-fixed, paraffin-embedded tissue and commercial antisera, we evaluated the usefulness of immunohistochemical staining for carcinoembryonic antigen (CEA) and keratin in the diagnosis of malignant mesothelioma. All 18 adenocarcinomas of lung examined stained for CEA, usually strongly, while only eight of 22 mesotheliomas stained for CEA and the staining was generally weak. Staining for keratin was observed in 10 of 22 mesotheliomas and 12 of 18 adenocarcinomas; there were no differences in intensity of staining between the groups. We conclude that strong diffuse staining for CEA favors a diagnosis of carcinoma, and negative staining for CEA is against a diagnosis of carcinoma, but these are relative and not absolute criteria. We find that staining for keratin is of no use in distinguishing these types of tumors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201076     DOI: 10.1097/00000478-198404000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  22 in total

Review 1.  Malignant mesothelioma.

Authors:  R Rudd
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

2.  Blood group antigens, Lewisx and Lewisy in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma.

Authors:  D Jordon; J Jagirdar; M Kaneko
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

3.  New marker for mesothelioma: an immunoperoxidase study.

Authors:  A Donna; P G Betta; D Bellingeri; A Marchesini
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

4.  HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.

Authors:  A D Kennedy; G King; K M Kerr
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

5.  Immunohistochemistry in the diagnosis of malignant mesothelioma.

Authors:  M Pfaltz; B Odermatt; B Christen; J R Rüttner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

6.  Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.

Authors:  K Sheibani; H Battifora; J S Burke
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

7.  Localized fibrous tumour of serosal surfaces. Immunohistochemical and ultrastructural evidence for a type of mesothelioma.

Authors:  J Doucet; I Dardick; J R Srigley; A W van Nostrand; M A Bell; H J Kahn
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

8.  Peritoneal cystic mesothelioma: an electron microscopic and immunohistochemical study of two male patients.

Authors:  I K Sienkowski; A J Russell; S A Dilly; B Djazaeri
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

9.  Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.

Authors:  T Kawai; S D Greenberg; L D Truong; C A Mattioli; M Klima; J L Titus
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

10.  Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.

Authors:  H Moch; M Oberholzer; P Dalquen; W Wegmann; F Gudat
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.